Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...

Federal health officials say all lots of a nasal spray product distributed nationwide is being recalled due to microbial ...

The FDA has approved intranasal etripamil (Cardamyst; Milestone Pharmaceuticals) for the acute treatment of paroxysmal supraventricular tachycardia (PSVT), making it the first self-administered, ...

The U.S. Food and Drug Administration has announced a nationwide recall of nasal spray, which officials report has been found ...

Publix posted Monday that its stores are included in last week's recall of ReBoost Nasal Spra y, which "has been found to ...